KCL, the fourth oldest university in England, is one of the top 25 universities in the world (2016/17 QS international world rankings). The IoPPN, a School of KCL, is Europe’s largest centre for research and postgraduate education in psychiatry, psychology, basic and clinical neuroscience. The IoPPN has three Divisions: Academic Psychiatry, Neuroscience and Psychology & Systems Sciences. IoPPN is the second most cited research centre in the world as ranked by Thomson ISI Essential Science Indicators.
MUI is a young research centre, founded in 2004, with 3 000 students. It is the most important medical research and training facility in western Austria. It has 10 administrative divisions, 9 preclinical departments with 22 divisions and 21 clinical units. DP is part of the Dept. Physiology & Medical Physics and has six working groups whose major research focus are nociception, calcium signalling, cell membranes and renal and alveolar epithelial physiology.
UKW is an independent public higher education University Hospital with 19 Departments including ambulatory centres as well as four scientific institutes. The UKW is academically part of the University of Würzburg, a public institution, and belongs to the Medical Faculty. Per year > 55 000 patients are treated at UKW and > 200 000 are treated as outpatients. DN has particular and long-standing clinical and research expertise in the field of peripheral neuropathies and neuropathic pain. In the last decade, several human and animal research studies on the pathophysiology of neuropathic pain have been performed at DN.
Bionorica research GmbH is a subsidiary of Bionorica SE, a leading German manufacturer of herbal medicines worldwide, in Innsbruck, Austria. The business is committed to discovering and utilizing active plant ingredients for the development of rational phytopharmaceuticals. His research is focused on analytical investigation of natural products and complex herbal mixtures. For this purpose a new laboratory was established in 2008. With this lab, Bionorica research has a wide range of high-end analytical instruments available for analytical investigation of complex samples like biological fluids or herbal material. Furthermore, Bionorica research has a strong expertise for preparative purification of plant constituents as well as for the separation of complex mixtures. In 2010 and 2014 the laboratories and the equipment were expanded.
KI was founded in 1810 and is one of Europe’s largest and most prestigious medical universities. KI consistently ranks among the top universities in the world on a number of prestigious ranking tables (QS) and is also ranked top 10 medical universities in world. The Dept. of Physiology & Pharmacology is world leading and the Division of Pharmacology was placed in position fifth in recent international rankings.
FSU was established in 1558 and is counted among the 20 oldest universities in Germany. It is affiliated with 6 Nobel Prize winners. The Medical Faculty of the FSU (UKJ) with its 25 clinical centers and 27 institutes provides care for 250 000 in- and outpatients per year and teaching for 2 200 students of medicine and dentistry. UP1 is one of the largest centers of preclinical pain research in Germany with a main focus on musculoskeletal pain.
Kancera AB is a preclinical stage biotech company developing small molecule drugs against cancer and cancer-associated pain. The company is since 2011 listed on Nasdaq First North in Stockholm. The company is currently developing drugs for the treatment of leukemia and solid tumors, based partly on blocking survival signals in the cancer cell and partly on metabolic strangulation.
Eli Lilly was founded in 1876, with headquarters located in Indianapolis, US, and with operations based in the US and EU. Eli Lilly is now the tenth largest pharmaceutical company in the world with circa 39 000 employees, of which 8 000 are working in R&D. Eli Lilly has a broad interest in developing new therapies in the areas of neurodegenerative diseases and pain. Eli Lilly has been operating in the UK since 1934 and has four sites: UK Headquarters in Basingstoke, Erl Wood Research Centre in Windlesham, Speke Manufacturing Operations in Liverpool, and Bio-Tech Manufacturing in Dundee. Today, over 600 people, representing 45 different nationalities and 30 different functional disciplines, work at Erl Wood on both discovery and development of the new potential medicines in the pipeline.
Mabtech is a privately owned Swedish biotech company that emerged from the Department of Immunology at Stockholm University in 1986. Mabtech develops and manufactures high quality monoclonal antibodies and kits for ELISA, ELISpot and FluoroSpot. Mabtech is a world leader in development of ELISpot products and technology and T-cell measurements.
Founded in 2000, EURICE provides comprehensive support services for the planning, initiation, and implementation of international collaborative research and innovation projects. EURICE has been involved in EU-Framework Programmes since FP4 and has been supporting researchers in more than 250 EU funded projects to date. Within Horizon 2020, EURICE has been successfully involved in the coordination of 21 collaborative projects – among them 3 MSCA Innovative Training Networks. According to the most recent (Oct 2016) H2020 monitoring report, EURICE belongs to the Top 5 of SMEs in Europe regarding the number of signed H2020 agreements. EURICE is among Europe’s largest project management offices, with a team of over 40 staff members with different professional and scientific expertise, such as law, medicine, biology, communications, social and computer sciences.
AS is the UK’s leading dementia support and research charity. Since AS started to fund research in 1990, she has spent almost £30 million on cutting-edge projects investigating the cause, cure, care and prevention of all types of dementia. This pioneering research has involved over 500 scientists and clinicians, more than 250 people with a personal experience of dementia and the awarding of 225 research grants. Resulting in the publication of over 400 peer-reviewed papers.
Dr. Marzia Malcangio (female) is the Project Coordinator of the Marie Skłodowska-Curie ITN TOBeATPAIN. She is Professor of Neuropharmacology and group leader for Pain. She is an expert in neuro-immune interactions in chronic pain. She supervises the ESR 1
Dr. Clive Ballard (male) is a leading expert in Alzheimer’s disease. He is currently Visiting Professor of Age Related Diseases, and was Director of the Biomedical Research Unit for Dementia (2013 – 2016). He co-supervises the ESR 1
Dr. Susan Duty (female) is Reader in Pharmacology and Neuroscience, and group leader for Neurodegeneration and Co-Director of Wolfson CARD. She is an expert in Parkinson’s disease. She supervises the ESR 2
Dr. R. Chaudhuri (male) is Professor of Neurology & Movement Disorders, Consultant Neurologist, and Medical Director of the National Parkinson Foundation International Centre of Excellence. He is leading expert on Parkinson’s disease. He co-supervises the ESR 2 and ESR 6
Dr. Michaela Kress (female) is Full Professor and Head of Department. She is also group leader for Neurophysiology. She supervises the ESR 6, and co-supervises the ESR 8 and ESR 10. She is an expert in neuroinflammation and pain processing in a model for Fabry Anderson disease.
Priv.-Doz. Dr. Michiel Langeslag (male) is an Assistant Professor. He co-supervises the ESR 6. He is an expert in neuroinflammation and pain processing in a model for Fabry Anderson disease, electrophysiology, and microscopy.
Dr. Hans-Georg Schaible (male) is Professor of Physiology and Director of the Institute of Physiology I. He supervises the ESR 7, and co-supervises the ESR 4. He is an expert in neuro-immune interactions in arthritis, neuronal mechanisms of joint pain.
Dr. Frank Richter (male) is Professor of Physiology. He supervises the ESR 8. He is an expert in Expertise: assessment of brain homeostasis with ion selective electrodes, cortical spreading depression, pain-related electrophysiology of joint nociceptors.
Dr. Andrea Ebersberger (female) is “Privatdozent” Dr. rer. nat. of Physiology. She co-supervises the ESR 7, and the ESR 9. She is an expert in pain-related electrophysiology of nociceptive sensory neurons and spinal cord, neuroimmune interactions.
Dr. Claudia Sommer (female) is Deputy Medical Director, Department of Neurology. She supervises the ESR 9. She is an expert in antibody mediated diseases, diagnosis and pathophysiology of peripheral neuropathy, and pathophysiology of neuropathic pain.
Dr. Thomas Olin (male) is the CEO. He has more than 20 years’ experience of scientific and business management from biotechnology and pharmaceutical companies. He supervises the ESR 5. He is an expert in pharmacology, preclinical and early clinical drug development.
Dr. Johan Schultz (male) is Senior project leader, Biophysical chemistry, teaching epigenetics within the European Corporation in Science and Technology. He co-supervises the ESR 4. He is an expert in structural biology and biochemistry, and preclinical drug development.
Dipl.-Ing. Astrid Neumann (female) is the Head of the Bioanalytics Department. She supervises the ESR 10. She is an expert in qualitative and quantitative secondary metabolite analysis in biological fluids using mass spectrometric techniques (LC-MS and GC-MS).
Dr. Stefan Schönbichler (male) is the Head of the Analytical Department. He co-supervises the ESR 9. He is an expert in analytical characterization of herbal products and metabolite profiling using mass spectrometric techniques, MS-based dereplication strategies for secondary plant metabolites in plant material, extracts and herbal medicines with LC-MS and GC-MS.
Dr. Michael O’Neill (male) is Research Fellow. He co-supervises the ESR 2. He is an expert in molecular pathology.
Dr. Keith Wafford (male) is Principal Research Scientist. He co-supervises the ESR 1. He is an expert in pharmaceutical neuroscience.
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie Grant Agreement No 764860.